ArticleAnnals of gastroenterological surgery2026
Risk Factors for Small-for-Size Syndrome Grade B/C After Simultaneous Splenectomy in Adult Living-Donor Liver Transplantation.
Article in Annals of gastroenterological surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- More Liver Volume Is Necessary for High Risk Living Donor Liver Transplantation Candidates.Annals of gastroenterological surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Small-for-size syndrome (SFSS) after adult living-donor liver transplantation (LDLT) is a poor prognostic condition. Splenectomy (Spx) has recently been reported to help prevent SFSS and improve outcomes. This study aimed to identify risk factors for SFSS that occur despite Spx at the time of LDLT. Methods: This single-center retrospective study included 973 LDLT recipients from 2001 to 2024. Of these, 577 who underwent concomitant Spx were analyzed. SFSS grading followed the 2023 International Liver Transplantation Society consensus criteria. Prognostic factors associated with SFSS grade B/C, which required perioperative portal vein inflow control, were identified. Results: SFSS grade B/C occurred in 105 patients (18.2%) and was associated with significantly worse prognosis than grade 0/A (1-year survival: 93.9% vs. 81.9%, Conclusions: SFSS grade B/C still occurred in nearly one in five patients who underwent Spx for SFSS risk mitigation during LDLT. Patients with a high recipient NLR, MELD score, or donor age are at increased risk of SFSS despite Spx. Future strategies should emphasize careful donor selection and perioperative portal inflow modulation for high-risk cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.